IGKV1D-33

Across TCGA pan-cancer cohorts, IGKV1D-33 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of IGKV1D-33’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where IGKV1D-33 RNA is repressed in tumor relative to normal tissue. In most cancer types IGKV1D-33 is over-expressed in tumor, although a few such as COAD and BRCA show the opposite, repressed pattern.

COAD, LUAD, and BRCA are the cancer types where IGKV1D-33 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in IGKV1D-33 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	All	−1.524	<.001	8	view →
LUAD	Female	All	+1.550	<.001	7	view →
BRCA	Female	II,III,IV	−0.408	.001	6	view →
KIRC	All	All	+0.293	.005	4	view →
READ	All	All	−1.617	<.001	3	view →
ESCA	Female	All	+2.216	.025	1	view →
LUSC	All	All	+0.543	.030	1	view →
THCA	All	All	−0.341	.040	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

IGKV1D-33–COAD

Open the COAD breakdown →